Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5 in the footer, indicating a new site release.
    Difference
    0.0%
    Check dated 2026-06-05T12:54:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The Publications section no longer lists a previously cited study (CheckMate 038 immunomodulatory effects). This reduces the number of references linked to this trial record.
    Difference
    0.0%
    Check dated 2026-05-29T08:56:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a small backend or metadata update. No study details or user-facing content were altered.
    Difference
    0.0%
    Check dated 2026-05-15T02:22:20.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - The page revision label was updated from v3.5.2 to v3.5.3, indicating a maintenance or template update. The change does not modify the displayed study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-30T18:53:40.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible changes to the study details on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:11:52.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added the NEJM 2015 paper by Larkin et al. on Combined Nivolumab and Ipilimumab for untreated melanoma; removed the Erratum entry for that publication.
    Difference
    0.0%
    Check dated 2026-04-02T04:56:33.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.